Recombinant IGF-1 therapy has shown limited effects in enhancing motor function in DMD patients20, and transgenic overexpression in mdx mice increased fibre size21 but did not alter muscle IGF-1 concentration. Here, IGF1 is linked to Duchenne muscular dystrophy.